Cambridge, Mass.-based Beth Israel Lahey Health recorded an operating income of $60.2 million (2.3% margin) in the first quarter of 2026, up from an operating loss of $2.7 million (-0.1% margin) during the same period last year, according to its Feb. 27 financial report.
The system recorded total operating revenue of $2.6 billion for the three months ended Dec. 31, up from $2.4 billion during the same quarter last year. Net patient service revenue was $2 billion, up from $1.9 billion. Other revenue was $516 million, up from $421.7 million.
Total operating expenses were $2.5 billion in the first quarter of 2026, up from $2.4 billion during the same period last year. Salaries and benefits totaled $1.4 billion, up from $1.3 billion. Supplies and other expenses were $977.1 million, up from $962.1 million.
Beth Israel Lahey reported a net income of $104.8 million in the first quarter of 2026, up from $7.5 million during the same period last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
